EAM Investors’s Invivyd IVVD Stock Holding History

EAM Investors’s Portfolio IVVD Stock Details IVVD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,289	Closed	-$1.24M	–	326
2021 Q3	$1.24M	Buy	+29,289	New	+$1.09M	0.21%	235

Other funds holding IVVD

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

EAM Investors's IVVD Position: Q4 2021 in Review

EAM Investors sold out of Invivyd (IVVD) in Q4 2021, closing a stake of 29,289 shares — an estimated $1.24M sold.

EAM Investors first reported a position in IVVD in Q3 2021 and held it in 1 quarter. The position peaked at $1.24M in Q3 2021. 80 funds tracked by Wall St. Rank hold IVVD as of Q4 2021.

EAM Investors reported no remaining Invivyd position as of Q4 2021 after selling out during the quarter.
EAM Investors sold 29,289 Invivyd shares in Q4 2021, an estimated $1.24M.
EAM Investors first reported a position in Invivyd in Q3 2021 and held it in 1 quarter.
EAM Investors's Invivyd position peaked at $1.24M in Q3 2021.
80 funds tracked by Wall St. Rank held Invivyd as of Q4 2021.

Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.